首页> 美国卫生研究院文献>BMC Cancer >Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized multicenter active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

【2h】

Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized multicenter active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

机译：立格非司亭与培非司亭的疗效和安全性：接受阿霉素/多西他赛化疗的乳腺癌患者的随机多中心主动控制3期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundLipegfilgrastim is a novel glyco-pegylated granulocyte-colony stimulating factor in development for neutropenia prophylaxis in cancer patients receiving chemotherapy. This phase III, double-blind, randomized, active-controlled, noninferiority trial compared the efficacy and safety of lipegfilgrastim versus pegfilgrastim in chemotherapy-naïve breast cancer patients receiving doxorubicin/docetaxel chemotherapy.

机译：背景Lipegfilgrastim是正在接受化疗的癌症患者预防中性粒细胞减少症发展中的新型糖聚乙二醇化粒细胞集落刺激因子。这项III期，双盲，随机，主动控制，非劣效性试验比较了利培非司亭和培非司亭在未接受化疗的未接受阿霉素/多西他赛化疗的乳腺癌患者中的疗效和安全性。

著录项

期刊名称 BMC Cancer
作者
Igor Bondarenko; Oleg A Gladkov; Reiner Elsaesser; Anton Buchner; Peter Bias;
展开▼
作者单位

展开▼
年(卷),期 2013(13),-1
年度 2013
页码 386
总页数 12
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Neutropenia Febrile neutropenia Breast cancer Recombinant granulocyte-colony stimulating factor Lipegfilgrastim Pegfilgrastim;

机译：中性粒细胞减少症;发热性中性粒细胞减少症;乳腺癌;重组粒细胞集落刺激因子;Lipegfilgrastim;Pegfilgrastim;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy [J] . Igor Bondarenko, Oleg A Gladkov, Reiner Elsaesser, BMC Cancer . 2013,第1期

机译：立格非司亭与培非司亭的疗效和安全性：接受多柔比星/多西他赛化疗的乳腺癌患者的一项随机，多中心，主动控制的3期临床试验
2. Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy [J] . Zsuzsanna Kahan, Daniela Grecea, Martin Smakal, BMC Cancer . 2019,第1期

机译：RGB-02的功效和安全性，Pegfilgrastim BioSimilar，以防止化疗诱导的中性粒细胞率：随机，双盲期III临床研究的结果与接受化疗的乳腺癌患者参考PEGFILRASTIM
3. A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel [J] . Gladkov Oleg, Moiseyenko Vladimir, Bondarenko Igor N., The oncologist . 2016,第1期

机译：Balugrastim和Pegfilgrastim对接受阿霉素和多西他赛化疗的乳腺癌患者的III期研究
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Efficacy and safety of RGB-02 a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy [O] . Zsuzsanna Kahan, Daniela Grecea, Martin Smakal, 2019

机译：pegfilgrastim生物仿制药可预防化疗引起的中性粒细胞减少症RGB-02的功效和安全性：随机双盲III期临床研究与参比的pegfilgrastim对比在接受化疗的乳腺癌患者中的结果
7. Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy [O] . Igor Bondarenko, Oleg A Gladkov, Reiner Elsaesser, 2013

机译：立格非司亭与培非司亭的疗效和安全性：接受阿霉素/多西他赛化疗的乳腺癌患者的随机，多中心，主动控制3期临床试验
8. Randomized Trial of Neuroprotective Effects of Erythropoietin in Patients Receiving Adjuvant Chemotherapy for Breast Cancer: Positron Emission Tomography and Neuropsychological Study [R] . Abraham, J. 2008

机译：促红细胞生成素对接受乳腺癌辅助化疗的患者的神经保护作用的随机试验：正电子发射断层扫描和神经心理学研究

Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized multicenter active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅